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Abstract Activins are members of the TGF-[~ superfamily and 
are classified into 3 types: activin A, which consists of a 
homodimer of [~A, activin B, which consists of a homodimer of 
[~n, and activin AB, which consists of a heterodimer of ~A[~B. We 
studied the expression of activin mRNAs by RT-PCR in normal 
human epidermis, cultured keratinocytes, and DJM-1 cells (a 
squamous cell carcinoma line). We could detect only activin A 
mRNA ([~A) in normal human epidermis. In cultured keratino- 
cytes and DJM-1 cells, activin [~A mRNA was observed at 4 h but 
not at 96 h after plating. Activin A activity was detected in the 
conditioned medium of DJM-1 cells within 48 h. In addition, 
although foilistatin mRNA was not observed in human epidermis 
in situ, it was transiently expressed in cultured ceils at 4 h after 
plating. These findings suggest that the expression of these 
molecules in keratinocytes i associated with cell proliferation. In 
an in vitro tissue injury model, activin A was observed at the 
wound edge, where cell migration and proliferation may be 
activated. In DJM-1 cells cultured for 92 h, [~A mRNA was 
observed 4 h after injury treatment. These findings suggest hat 
activin A acts as a potent inducer of proliferation in vitro, at least 
in keratinocytes. 
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1. Introduction 
Activin, a member of the TGF-]3 superfamily that was ori- 
ginally purified from ovarian fluids, stimulates secretion of 
follicle-stimulating hormone from the anterior pituitary gland 
[1,2]. Erythroid differentiation factor (EDF) was independ- 
ently isolated from human monocytic leukemia cells [3]. Mo- 
lecular cloning of cDNA has shown that activin and EDF  are 
identical. Activins have been identified as homo- or heterodi- 
mers of the ~a and ~B chain and have been classified into 
three types: activin A, consisting of lIAnA, activin AB, con- 
sisting of ]3A]3B, and activin B, consisting of ]]B]]B. Further- 
more, ]]-chains can also form heterodimers with distantly re- 
lated a subunits that generate inhibin A (~X]3A) and inhibin B 
(a~B), which inhibit activin [1,2]. 
Follistatin, an inhibitor of follicle-stimulating hormone se- 
cretion from the pituitary gland, is an activin-binding protein 
[4]. The interaction between activin A and f011istatin appears 
to inhibit significantly activin A activity in extragonadal tis- 
sues [5]. 
*Corresponding author. Fax: (81) (58) 265-9017. 
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Activins are involved in erythroid differentiation [6], regula- 
tion of neural differentiation [7,8], stimulation of glycogeno- 
lysis in hepatocytes [9] and mesoderm induction [10,11]. Acti- 
vin A is also expressed in arteriosclerotic lesions [12]. 
However, little is known about the role of activins in skin. 
Roberts et al. [13] reported that activin [~A is expressed in the 
developing hair bulb and also in the dermal layer of embry- 
onic skin, but not in adult skin. Since TGF-[~ modulates pro- 
liferation and differentiation [14], it is conceivable that acti- 
vins also have such functions in keratinocytes. We 
investigated expression of activins in human epidermis, a 
non-differentiating squamous cell carcinoma cell line (DJM- 
I cells), and cultured normal keratjnocytes at the protein and 
mRNA level. 
2. Materials and methods 
2.1. Cell culture 
An isolated cell line (DJM-1 cells) from human skin squamous cell 
carcinoma [15,16] was cultured in 1.8 mM Ca 2+ medium containing 
Eagle's minimum essential medium (MEM), 10% fetal calf serum, 100 
/ag/ml of streptomycin and 100 U/ml of penicillin. Normal human 
keratinocytes obtained from foreskin (Kurabo, Osaka, Japan) were 
cultured in keratinocyte-SFM (modified MCDB medium supplement- 
ed with 5 ng/ml of epidermal growth factor, 50 p.g/ml of bovine 
pituitary extract, 50 ~tg/ml of gentamicin, and 0.25 /ag/ml of ampho- 
tericin B) (Life Technologies Inc., Grand Island, NY). The medium 
was changed every 2 3 days. After reaching confluence, the cells were 
treated with Hank's balanced salt solution containing 0.02% trypsin 
and 0.02% EDTA for 15 rain at 37°C, and were then resuspended in 
the culture medium. The third passage of human keratinocytes was 
used for experiments. Both DJM-1 cells and normal keratinocytes 
were seeded in 60-mm dishes at a density of 1 × 105 cells/5 ml of 
culture medium in the presence of 0.09 mM (low-dose) or 1.8 mM 
(normal-dose) calcium, since it is known that a low concentration of
calcium in the medium induces proliferation and normal concentra- 
tion induces differentiation [17,18] for keratinocytes. They were cul- 
tured at 37°C in humidified 5% CO2/95% air. 
2.2. Reverse transcription polymerase chain reaction (RT-PCR) 
Messenger RNA was extracted from human epidermis and DJM-1 
cells and normal keratinocytes cultured in MEM containing 0.09 or 
1.8 mM calcium using a kit for mRNA purification (QuickPrep, Phar- 
macia AB, Uppsala, Sweden) [19]. The epidermis was separated from 
skin biopsy specimens by incubation with 1000 U/ml of dispase (Godo 
Shusei Co., Tokyo, Japan) at 37°C for 2 h or at 4°C overnight. 
Complementary DNA was synthesized from mRNA, and PCR was 
performed using an RNA PCR (AMV) kit (Takara Shuzo Co., Ltd., 
Otsu, Japan). The oligonucleotide primers used were based on the 
DNA sequence of rat activin subunits [20,21]. The primer for inhibin 
a, 5'-TGACTTCAGCCCAGCTGTGG-3', was used together with a 
reverse primer, 5'-GGCACCAAAAACAGGGGCTG-3' correspond- 
ing to the sequence Va1127 Pro 322 to amplify a 586 base pair (bp) 
fragment. The primer for activinq3A, 5'-GAACAGTGCCAGGA- 
GAGCGG-3', was used together with a reverse primer, 5'- 
AGGTTGGCAAAGGGGCTGTG-3' corresponding to the sequence 
All rights reserved. 
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3. Results 
onto 96-well microtiter plates in Ham F-12 medium containing 10% 
FCS with or without 30 ~tg/ml of porcine follistatin. After 6 days, the 
degree of erythroid ifferentiation was determined microscopically by 
counting the number of dianisidine-stained cells; the result is ex- 
pressed as the percentage of cells. The activin A activity in the con- 
ditioned medium was determined based on a dose-dependent differ- 
entiation curve using various concentrations of recombinant activin 
A. 
FiB 1. Immunofluorescence findings for activin A. (A) Activin A 
stai ring was enhanced at the wound edge of DJM-1 cells after 92 h 
cuh are and subsequent 4 h cultivation. (B) Marked reduction of ac- 
tivi ~ A staining by preabsorption of the antibody with human acti- 
vin A. (C) Activin A was not stained in most cells cultured for 96 h 
wit Lout injury treatment. Arrowheads indicate the wound edge. 
Ba~: 25 ~tm. 
Gh 245-Leu 38~ to amplify a 423-bp fragment. For activin-I]B, the pri- 
me~ 5'-GTGGTGCCTGTGTTCGTGGA-3' and a reverse primer, 5'- 
TT 2ACCGGCCCAGGGTTCAG-3' corresponding to the sequence 
Va  '4~-Asu~49 were used to amplify a 330-bp fragment. Amplification 
wa, performed for 30 cycles of 1 rain at 94°C, 30 s at 65°C, and 2 rain 
at 2°C.  For follistatin, the oligonucleotide primers were based on the 
D!XA sequence of human follistatin [5,22]. The sense primer, 
5'-~ ~TCGAGGATCCCTGGGAACTGCTGGCTCCGTCAAGC-3' 
(th, 113-137 oligonucleotide position of human follistatin and an 
ext a BamHI restriction enzyme site) was combined with an antisense 
primer, 5' -CCTAGAAGCTTGCCCAGCAGGCAGGTAGCCTTT- 
CqC-3' (the 688-712 position and an HindIII site), to generate a
pulative 622-bp cDNA fragment. Amplification was performed for 
30 cycles of 1 rain at 94°C, 2 min at 55°C, and 5 min at 72°C. 
PC R products were separated on 2% agarose gel and visualized 
wi~ 1 ethidium bromide. 
2.3 Tissue injury model of cultured keratinocytes 
• 'o examine the effect of tissue injury on the expression of activin A, 
we scraped off some cultured cells and examined expression of activin 
~A mRNA in the remaining cells by RT-PCR. This treatment is con- 
sid::red to be an in vitro model of tissue injury that induces cell 
mi!:ration and proliferation [23]. Briefly, three 3-mm wide strips 
we e marked with a razor blade on a dish of DJM-I cells cultured 
fol 92 h, and the cells in the strips were removed with a cell scraper. 
Th,: remaining cells were cultured for a further 4 h and harvested for 
R/':A extraction. Localization of activin A was also studied by im- 
ml nofluorescence microscopy. Coverglass lips were placed on the 
dis.a and DJM-1 cells or normal keratinocytes were cultivated for 92 
h. Cells in the strip on coverglass lips were scraped off with a cell 
sc~ lper as described above, and the remaining cells were cultured for a 
fur ther 4 h. Cells adhering to the coverglass slips were fixed with 3% 
pa' aformaldehyde in PBS. The fixed cells were soaked in a solution of 
0.(15% Triton X for 10 min at room temperature, incubated with anti- 
ac~ivin A antibody [21]. The antibody reacts with both the dimer and 
m, nomer of the ~a subunit, but does not crossreact with inhibin A, a 
helerodimer of c~ and t~A [2]. After 30 min, sections were washed with 
PI~S, incubated with fluorescein-conjugated goat anti-rabbit IgG 
(1 100, Cappel, Durham, NC), washed again with PBS, and observed 
urter  an immunofluorescence microscope (Nikon FX, Nikon, Tokyo, 
Ja:,an). 
2.~ Determination of activin A activity in the culture medium 
kctivin A activity was estimated by measuring activin A-induced 
er5 throid differentiation of F5-5 cells [3,7,6]. Normal keratinocytes or
D.IM-I cells were incubated (1 × 105 cells in 5 ml of MEM+10% FBS/ 
60mm culture dish) for 48 h and the culture medium was collected. 
The cells were then cultured in new culture medium for 48 h and the 
m~dium was again collected. F5-5 cells (5 × l0 s cells/ml) were plated 
m 
3.1. Localization o f  activin A in tissue injury model in 
cell-culture system 
Marked  staining for activin A was observed at the wound 
edge of  DJM-1 cells (Fig. 1A) in the in vitro model  o f  tissue 
injury. Preabsorpt ion  o f  the ant ibody with an excess o f  pur- 
ified human activin A (10 ~tM) markedly reduced the intensity 
o f  staining at the wound edge (Fig. 1B) and no activin A 
staining was observed in cells not  subjected to injury treat- 
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Fig. 2. (A) RT-PCR with mRNA for inhibin c~, activin [~A and ISB 
subunits in normal human epidermis (lanes 2~,) and in DJM-1 cells 
cultured for 4 h (lanes 5-7), for 48 h (lanes 8-10) and for 96 h 
(lanes 11 13) in normal calcium medium. Expression of activin 13A 
mRNA (423 bp) was detected in lanes 3,6. T, epidermis; N, normal 
calcium medium. (B) RT-PCR with mRNA for inhibin c~, activin 
I3A and 13B subunits in normal keratinocytes (lanes 24)  and in 
DJM-1 cells cultured for 4 h (lanes 5-7), for h (lanes 8-10) and 96 
h (lanes 11 13) in low calcium medium. Activin [3A mRNA was de- 
tected in lanes 3,6,9. L, low calcium medium; N-KERA, normal 
keratinocytes. Lane 1 in (A,B) indicates the DNA size marker 
(0174/DNA digested with HaeIII). 
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Fig. 3. Expression of mRNA for activin ]~A (423 bp) in normal hu- 
man keratinocytes cultured for 4 h (lanes 2,5), 48 h (lanes 3,6) and 
96 h (lanes 4,7) in low calcium medium (lanes 2~,) and in normal 
calcium medium (lanes 5-7). The DNA size marker (¢174/HaeIII di- 
gest) is shown in lane 1. L-Ca, low calcium medium; N-Ca, normal 
calcium medium. 
ment (Fig. 1C). Similar findings were observed in a tissue 
injury model using cultured normal human keratinocytes 
(data not shown). 
3.2. Expression of mRNAs for a, flA and fib subunits in cultured 
keratinocytes and in human epidermis 
Although PCR products corresponding to mRNA for ct 
and ~lB subunits were not observed, the expected PCR product 
corresponding to mRNA for the t]a subunit (423 bp) was 
detected in human epidermis, cultured human keratinocytes, 
and DJM-1 cells. Expression of the [3A subunit was observed 
at 4 and 48 h, but not at 96 h in DJM-1 cells cultured with 
low calcium. In cells cultured with 1.8 mM calcium, the PCR 
product for I3A was detected only at 4 h and not at 48 or 96 h 
(Fig. 2). The same results were obtained in normal human 
keratinocytes, although the PCR product band was faint at 
48 h in both low and normal calcium medium (Fig. 3). The 
PCR product for follistatin (622 bp) was not detected by RT- 
PCR in human epidermis. However, PCR products were de- 
tected at 4 h in human keratinocytes cultured with low and 
normal calcium. In DJM-1 cells, the PCR product for folli- 
statin was detected only at 4 h in the normal calcium MEM, 
and remained etectable for up to 48 h in cells cultured with 
low calcium (Fig. 4). 
3.3. Re-expression ofmRNA for activin flA and follistatin after 
tissue injury in the cell culture system 
In DJM-I cells, the expected PCR products for activin 13A 
(423 bp) and follistatin (622 bp) were detected at 4 h after 
injury treatment; hese findings were not affected by the cal- 
cium concentration i the medium. Trypsin treatment (0.02%) 
for 20 min also induced expression of mRNAs for activin 13A 
and follistatin (Fig. 5). Uninjured cells did not induce mRNA 
for follistatin (lanes 3,5) or 13A (lanes 8,10). 
3.4. Existence of activin A activity in conditioned medium of 
DJM-1 cells 
The activin A activity in DJM-1 cells cultured for 2 days in 
the low calcium medium was determined with the F5-5 bioas- 
say. Endogenous activin A activity was completely neutralized 
by 30 p.g/ml of follistatin and corresponded to 8 ng/ml of 
recombinant activin A. Minimal activin A activity (less than 
1 ng/ml) was detected in the normal calcium medium. Activity 
was not detectable when cells were cultured for an additional 
2 days. Surprisingly, activin A activity was not detected in 
normal human keratinocytes (less than 0.5 ng/ml) under the 
same culture conditions used for DJM-1 cells. 
4. Discussion 
Activin A is found extensively in various organs, such as 
the ovary [2], pancreas [21], liver [9], while the distribution of 
inhibins is limited to the gonads and endocrine organs. In 
pancreatic islets, activin A coexists with glucagon in secretory 
granules in A-cells and with somatostatin D-cells. Activin 
A has been found to stimulate the secretion of insulin in the 
presence of 2.8 mM glucose [21]. Activin A also stimulates 
glucose output by glycogenolysis in rat hepatocytes [9]. How- 
ever, activin A has a mitogenic effect on osteoblastic cells 
(MC3T3-E1), especially in their undifferentiated state, and a 
suppressive effect on alkaline phosphatase activity, which is a 
marker of the differentiation of osteoblastic cells [5]. Activin 
A also inhibits neural and glial differentiation of undifferen- 
tiated P19 cells [7] and promotes the survival of P19 cells [8]. 
In the present study, RT-PCR showed expression of mRNA 
for the activin 13A subunit, but not for 13B and inhibin ct sub- 
units, in the epidermis. These observations indicate that acti- 
vin A, a homodimer of 13A, exists in normal human epidermis. 
Hfibner et al. [24] investigated the role of activin A in wound 
healing using an animal model. They detected low levels of 
mRNAs for activin I3A and inhibin ct in the dermis but not in 
the epidermis of mouse skin. They also detected abundant 13n 
mRNA in the dermis and a lower level in the epidermis. These 
results are not consistent with the present findings in human 
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Fig. 4. Expression of mRNA for follistatin (622 bp) at a relatively 
early stage of cultivation in both low and normal calcium media 
(positive in lanes 2,4,8,9,11) in cultured normal keratinocytes (lanes 
2-6) and DJM-1 cells (lanes 8-12). Lane 1 indicates the DNA size 
marker (¢~1741HaelII digest). L, low calcium medium; N, normal 
calcium medium; N-KERA, cultured normal keratinocytes; DJM-1, 
DJM-1 cells. 
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Fi:.. 5. Re-expression of mRNAs for follistatin (622 bp) (lanes 2,4) 
and activin [3A (423 bp) (lanes 7,9) in injured DJM-1 cells. Lane 1 
indicates the DNA size marker ffp1741HaeIII digest). L, low calcium 
medium; N, normal calcium medium; FOL, PCR product for folli- 
sta,:in mRNA; ACT, PCR product for activin A mRNA. 
ep dermis. The reason for this discrepancy is not clear, but it 
m~y be due to species-related differences. 
Cultured normal human keratinocytes xpressed mRNA for 
orJy the 13a subunit, indicating that they express activin A, 
but not activin AB or B. This finding is consistent with pre- 
vi,,us results in another epithelial cell line, FHs74|nt cells 
derived from human embryonic intestine [25]. The ~A 
mP, NA was detected only in the early stage (4 h) after inocu- 
lation in both low and normal calcium media. On the other 
hand, DJM-1 cells, a squamous cell carcinoma cell line, also 
exoressed 13A mRNA at 4 h in the normal calcium medium 
ar, d for up to 48 h in the low calcium medium. This prolonged 
e~ ~ression for ~a mRNA in the low calcium medium may be 
re ated to the effect of the low calcium condition on cell pro- 
lfl..'ration at least in DJM-1 cells. Activin A activity was de- 
te.:ted in DJM-1 cells, but not in normal keratinocytes, ug- 
gesting that activin A produced by DJM-1 cells is secreted 
in o the extracellular space in the early stage of cell prolifera- 
ti,,n. It is unclear why activin A activity was not detected in 
th.~ conditioned media of normal keratinocytes. The presence 
ot follistatin at the protein level may be related, although ~A 
mRNA was detected in both DJM-1 cells and keratinocytes. 
T~e prolonged expression of activin A and its activity in 
DIM-1 cells may be related to the transformation and in- 
c] zased proliferative ability of these cells, which is consistent 
th the activin A-promoted survival of P12 cells [8]. Various 
b~ 3logical events, such as cell division, cell migration, re-ex- 
p: ession of lost adhesion molecules, and cytokine production, 
o, cur in freshly plated cells. Thus, we further investigated the 
et'ect of injury on the expression of the activin [~A subunit 
u~ ing a cell culture system to confirm our results in freshly 
pared cells. This in vitro wounding model is a reasonable 
e~ perimental model of keratinocyte migration because it has 
been shown that after half of the confluent keratinocyte 
monolayer is removed, the remaining keratinocytes apparently 
migrate from the cutting edge to an open space during incu- 
bation for 16 h [23]. RT-PCR demonstrated expression of 
activin 13A mRNA at 4 h in wounded cells; activin A was 
also observed at the wound edge at the protein level. These 
in vitro results in wounded cells suggest hat activin A is 
involved in the migration and/or proliferation of keratino- 
cytes. Htibner et al. [24] observed a marked increase in activin 
I3A mRNA during the repair of wounded mouse skin. How- 
ever, they observed activin 13A mRNA in the dermis, not in 
the epidermis, by in situ hybridization. This discrepancy about 
the origin of activin A may be due to differences between in 
vivo and in vitro experiments. It is possible that various cy- 
tokines and growth factors in serum may preferably induce 
the expression of activin A in dermal cells during wound 
repair in vivo. Finally, the co-expression of follistatin 
mRNA and activin ~A mRNA in wounded DJM-1 cells in 
the present study suggests that follistatin modulates the func- 
tion of activin A in keratinocytes. 
In conclusion, activin A appears to play a role in the pro- 
liferating phase of wounded cells in vitro, at least in human 
keratinocytes. Further studies on the effect of activin A in 
human wounds at various stages of repair are needed to elu- 
cidate the function of activin A in keratinocytes. 
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